The Clorox Company (NYSE:CLX) Shares Purchased by Czech National Bank
The Clorox Company (NYSE:CLX) Shares Purchased by Czech National Bank
Czech National Bank boosted its position in The Clorox Company (NYSE:CLX – Get Rating) by 0.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,442 shares of the company's stock after buying an additional 129 shares during the quarter. Czech National Bank's holdings in Clorox were worth $2,027,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in Clorox by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 14,685,046 shares of the company's stock worth $2,041,661,000 after buying an additional 185,012 shares in the last quarter. BlackRock Inc. raised its stake in shares of Clorox by 5.6% in the 3rd quarter. BlackRock Inc. now owns 10,964,049 shares of the company's stock valued at $1,407,673,000 after purchasing an additional 580,982 shares in the last quarter. State Street Corp raised its stake in shares of Clorox by 9.6% in the 2nd quarter. State Street Corp now owns 8,907,083 shares of the company's stock valued at $1,255,721,000 after purchasing an additional 778,269 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Clorox by 2.4% in the 2nd quarter. Wells Fargo & Company MN now owns 3,557,161 shares of the company's stock valued at $501,489,000 after purchasing an additional 82,698 shares in the last quarter. Finally, Federated Hermes Inc. raised its stake in shares of Clorox by 11.1% in the 3rd quarter. Federated Hermes Inc. now owns 2,161,323 shares of the company's stock valued at $277,492,000 after purchasing an additional 215,425 shares in the last quarter. Institutional investors and hedge funds own 79.12% of the company's stock.
Get Clorox alerts:Clorox Price Performance
NYSE CLX opened at $157.50 on Friday. The Clorox Company has a 52 week low of $120.50 and a 52 week high of $160.59. The company has a current ratio of 0.86, a quick ratio of 0.47 and a debt-to-equity ratio of 5.04. The stock has a market cap of $19.46 billion, a price-to-earnings ratio of 45.00, a price-to-earnings-growth ratio of 3.12 and a beta of 0.29. The company has a 50-day moving average price of $150.56 and a two-hundred day moving average price of $144.96.
Clorox (NYSE:CLX – Get Rating) last posted its earnings results on Thursday, February 2nd. The company reported $0.98 EPS for the quarter, topping the consensus estimate of $0.66 by $0.32. Clorox had a net margin of 6.16% and a return on equity of 89.97%. The firm had revenue of $1.72 billion during the quarter, compared to analysts' expectations of $1.66 billion. During the same quarter in the prior year, the firm earned $0.66 EPS. Clorox's quarterly revenue was up 1.4% on a year-over-year basis. Analysts forecast that The Clorox Company will post 4.23 EPS for the current year.
Clorox Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, May 12th. Shareholders of record on Wednesday, April 26th will be given a $1.18 dividend. This represents a $4.72 annualized dividend and a yield of 3.00%. The ex-dividend date is Tuesday, April 25th. Clorox's dividend payout ratio (DPR) is 134.86%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on the stock. Barclays cut their target price on shares of Clorox from $110.00 to $108.00 and set an "underweight" rating on the stock in a research note on Monday, February 6th. JPMorgan Chase & Co. upped their target price on shares of Clorox from $126.00 to $135.00 and gave the company an "underweight" rating in a research note on Friday, January 13th. StockNews.com assumed coverage on shares of Clorox in a research note on Thursday, March 16th. They issued a "hold" rating on the stock. Jefferies Financial Group upped their target price on shares of Clorox from $140.00 to $145.00 and gave the company a "hold" rating in a research note on Wednesday, February 1st. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Clorox from $152.00 to $147.00 in a research note on Monday, March 20th. Seven equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $141.00.
Clorox Profile
(Get Rating)
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
Featured Articles
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- MarketBeat Week in Review – 3/20 – 3/24
- Dividend King Genuine Parts Company Upgraded On Profit Guidance
- The Bottom Is In For Accenture
- 11 Best Consumer Discretionary Stocks of 2023
- 5 Best Dividend Capture Stocks
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Get Rating).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
根據捷克國家銀行提交給美國證券交易委員會(美國證券交易委員會)的最新13F檔案,第四季度捷克國家銀行將其在高樂氏公司(紐約證券交易所代碼:CLX-GET評級)的頭寸提高了0.9%。該機構投資者在本季度額外購買了129股後,持有該公司14,442股股票。截至最近一個季度末,捷克國家銀行持有的Clorox股份價值202.7萬美元。
其他一些機構投資者最近也增持或減持了該公司的股份。先鋒集團(Vanguard Group Inc.)第一季度增持高樂氏1.3%的股份。先鋒集團現在持有14,685,046股該公司股票,價值2,041,661,000美元,上個季度又購買了185,012股。貝萊德股份有限公司在第三季度增持了高樂氏5.6%的股份。貝萊德股份有限公司在上個季度購買了580,982股後,現在持有10,964,049股該公司股票,價值1,407,673,000美元。道富銀行在第二季度增持了9.6%的高樂氏股票。道富銀行目前持有8,907,083股該公司股票,價值1,255,721,000美元,上一季度又購買了778,269股。富國銀行MN在第二季度增持了2.4%的高樂氏股票。Wells Fargo&Company MN在上個季度額外購買了82,698股後,現在擁有3,557,161股該公司股票,價值501,489,000美元。最後,聯合愛馬仕公司在第三季度增持了高樂氏11.1%的股份。聯合愛馬仕公司目前持有該公司2,161,323股股票,價值277,492,000美元,上個季度又購買了215,425股。機構投資者和對沖基金持有該公司79.12%的股票。
到達高樂氏警報:高樂氏性價比
紐約證交所CLX上週五開盤報157.50美元。高樂氏公司目前的52周低點為120.50美元,52周高點為160.59美元。該公司的流動比率為0.86,速動比率為0.47,債務權益比率為5.04。該股市值為194.6億美元,本益比為45.00倍,本益比為3.12倍,貝塔係數為0.29。該公司的50日移動均線價格為150.56美元,200日移動均線價格為144.96美元。
高樂氏(紐約證券交易所代碼:CLX-GET Rating)最近一次公佈財報是在2月2日星期四。該公司公佈本季度每股收益為0.98美元,比普遍預期的0.66美元高出0.32美元。高樂氏的淨利潤率為6.16%,股本回報率為89.97%。該公司本季度營收為17.2億美元,高於分析師預期的16.6億美元。去年同期,該公司每股收益為0.66美元。高樂氏季度營收同比增長1.4%。分析師預測,高樂氏公司本年度每股收益將達到4.23歐元。
高樂氏股息公告
該公司最近還宣佈了季度股息,將於5月12日(星期五)支付。4月26日(星期三)登記在冊的股東將獲得1.18美元的股息。這意味著年化股息為4.72美元,收益率為3.00%。除息日期為4月25日(星期二)。高樂氏的股息支付率為134.86。
華爾街分析師預測經濟增長
一些股票研究分析師最近發佈了關於該股的報告。巴克萊將高樂氏股票的目標價從110.00美元下調至108.00美元,並在2月6日週一的一份研究報告中將該股的評級定為“減持”。摩根大通將高樂氏股票的目標價從126.00美元上調至135.00美元,並在1月13日星期五的一份研究報告中給出了該公司“減持”的評級。斯托克新聞網在3月16日星期四的一份研究報告中對高樂氏的股票進行了報道。他們對該股的評級為“持有”。2月1日週三,傑富瑞金融集團將高樂氏股票的目標價從140.00美元上調至145.00美元,並在一份研究報告中給予該公司“持有”評級。最後,德意志銀行Aktiengesellschaft在3月20日星期一的一份研究報告中將高樂氏股票的目標價從152.00美元下調至147.00美元。7名股票研究分析師對該股的評級為賣出,6名分析師給予持有評級,1名分析師對該股給予買入評級。根據MarketBeat.com的數據,該公司的共識評級為持有,共識目標價為141.00美元。
高樂氏簡介
(獲取評級)
高樂氏公司從事消費品和專業產品的製造和營銷。它通過以下業務部門運營:健康和健康、家庭、生活方式和國際。健康和健康部分包括清潔產品、專業產品和維生素、礦物質和補充劑,主要在美國銷售和銷售。
專題文章
- 免費獲取StockNews.com關於高樂氏的研究報告
- 市場回顧周-3/20-3/24
- 紅利王正品配件公司利潤指引升級
- 埃森哲的底部已經到了
- 2023年11只最佳非必需消費品股票
- 5只最佳股利捕捉股
想看看還有哪些對沖基金持有CLX嗎?訪問HoldingsChannel.com,獲取高樂氏公司(紐約證券交易所代碼:CLX-GET評級)的最新13F檔案和內幕交易。
接受《高樂氏日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Clorox和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧